Missing/wrong data?
Log in to edit
STAT3 mediates Nilotinib response in KIT-altered Melanoma: a Phase II Multicenter Trial of the French Skin Cancer Network.
scientific article published on 23 August 2017
Author/s
author: Julie Delyon, Sylvie Chevret, Stéphane Dalle, Nicolas Meyer, Celeste Lebbe, Maxime Battistella
Work details
Publication date
August 24, 2017
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.